|
1. |
Challenging Skin Disorders: Introductory Comments |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 301-301
Larry Millikan,
Preview
|
PDF (36KB)
|
|
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
2. |
Erythema Gyratum Repens |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 302-305
Leigh Eubanks,
Elizabeth McBurney,
Richard Reed,
Preview
|
PDF (606KB)
|
|
摘要:
BackgroundErythema gyratum repens is a rare, clinically specific, and distinctive paraneoplastic syndrome. It is associated with internal malignancy in 82% of patients.ObjectiveA 58-year-old man with erythema gyratum repens is described. On diagnosis of his eruption, a malignancy work-up revealed a 9-mm pulmonary adenocarcinoma. Removal of the carcinoma resulted in clearing of the erythema.ResultsErythema gyratum repens is most commonly associated with bronchial, esophageal, and breast cancer. It has also rarely been reported in patients without evidence of malignancy. The histopathologic findings are nonspecific. Direct immunofluorescence has sometimes revealed C3, C4, or immunoglobulin G at the basement membrane zone.ConclusionThe etiology of erythema gyratum repens is unknown, although an immune response is postulated. Treatment involves treating the underlying malignancy.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
3. |
The Glucagonoma Syndrome: A Review of its Features and Discussion of New Perspectives |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 306-320
Mark Chastain,
Preview
|
PDF (374KB)
|
|
摘要:
Glucagonoma syndrome is a paraneoplastic phenomenon characterized by an islet alpha-cell pancreatic tumor, necrolytic migratory erythema, diabetes mellitus, weight loss, anemia, stomatitis, thromboembolism, and gastrointestinal and neuropsychiatric disturbances. These clinical findings in association with hyperglucagonemia and demonstrable pancreatic tumor establish the diagnosis. Glucagon itself is responsible for most of the observed signs and symptoms, and its induction of hypoaminoacidemia is thought to lead to necrolytic migratory erythema. Liver disease and fatty acid and zinc deficiency states may also contribute to the pathogenesis of the eruption in some cases. Most patients are diagnosed too late in the clinical course for cure, but successful palliation of symptomatology can usually be achieved with surgical and medical intervention. This paper reviews the glucagonoma syndrome, paying particular attention to its cutaneous features, and provides new perspectives in our current understanding of this phenomenon.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
4. |
Thalidomide and Its Dermatologic Uses |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 321-326
Michele Moraes,
Glenn Russo,
Preview
|
PDF (108KB)
|
|
摘要:
This article reviews how the drug thalidomide can be used for various dermatologic disorders. Also included is a short discussion of the chemistry and physiologic mechanisms of thalidomide. Thalidomide, now available again in the United States, is another drug that can be considered by dermatologists for some severe, unusual disorders.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
5. |
Cutaneous Reactions to Chemotherapeutic Agents |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 327-335
Robert Koppel,
Erin Boh MD,
Preview
|
PDF (550KB)
|
|
摘要:
The task of evaluating a cutaneous eruption in the patient receiving chemotherapy can be quite formidable. Most of the time, these patients are receiving a multitude of agents and have profound immunosuppression. These factors may alter the more common manifestations of cutaneous eruptions. This article presents some of the more common cutaneous eruptions that may occur in an oncology patient receiving chemotherapy. It is hoped we may recognize clinical patterns seen with chemotherapeutic agents in the immunosuppressed population and, by recognizing these cutaneous eruptions, we may avoid the pitfalls of discontinuing medicines that may certainly be needed or altering the treatment course in a patient.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
6. |
Sexual Dysfunction in Hypertensive Patients Treated with Losartan |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 336-341
José Luis Caro,
José Lozano Vidal,
José Vicente,
Maria Roca,
Carlos Bravo,
Miguel Sanchez Zamorano,
Carlos Ferrario,
Preview
|
PDF (127KB)
|
|
摘要:
BackgroundImpaired erectile function in men is a component of the dysmetabolic syndrome of high blood pressure as well as a sequela of antihypertensive therapy. This prospective interventional study in men with uncontrolled hypertension (blood pressure ≥140/90 mm Hg) used a survey instrument to assay sexual dysfunction before and after therapy with losartan.MethodsWe evaluated the influence of a 12-week therapy with losartan in 82 hypertensive subjects with (n = 82) and without (n = 82) a diagnosis of erectile dysfunction using a self-administered questionnaire validated in another 60 subjects with hypertension.ResultsFrom an initial sample of 323 hypertensive men and women, 82 men, aged 30 to 65 years, with sexual dysfunction underwent a 12-week regimen of losartan therapy (50–100 mg/day). Losartan treatment improved sexual satisfaction from an initial 7.3 to 58.5% (&khgr;2;P= 0.001). Subjects reporting a high frequency of sexual activity improved from 40.5% initially to 62.3% after drug treatment, whereas the number of patients with low or very low frequency of sexual activity decreased significantly (&khgr;2;P= 0.001). At the completion of the 12-week losartan regimen, only 11.8% of the treated subjects reported in improvement in sexual function. Improvement on quality of life was demonstrated in 73.7% of subjects medicated with losartan, 25.5% reported no changes, and only 0.8% felt worse. In the group without sexual dysfunction, losartan had a nonsignificant effect on sexual function.ConclusionsOur data suggest that losartan improved erectile function and both satisfaction and frequency of sexual activity. Because side effects are one of the most influential factors in the management of hypertension, an added benefit of losartan therapy may be its positive impact on quality of life.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
7. |
The Calciuric Response to Dietary Salt of Dahl Salt-Sensitive and Salt-Resistant Male Rats |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 342-347
Myrtle Thierry-Palmer,
Detrice Sherman,
Nerimiah Emmett,
Min Wang,
Mohamed Bayorh,
Naana Donkoh,
Preview
|
PDF (120KB)
|
|
摘要:
BackgroundThere are conflicting reports regarding the effect of salt sensitivity on the calciuric response to salt, perhaps because of gender differences and different modes of salt administration. We tested the hypothesis that the calciuric response to dietary salt would not differ for male Dahl salt-sensitive (S) and salt-resistant (R) rats.MethodS and R rats were fed high- (80 g/kg) or low- (3 g/kg) salt diets for 3 weeks and urine (24 hour) was collected weekly.ResultsUrinary calcium excretion was up to 20-fold greater for S and R rats fed a high-salt diet (P< 0.001) than for S and R rats fed a low-salt diet and did not differ significantly between S and R rats. S rats, however, excreted calcium in significantly higher urine volumes (P< 0.001) during high salt intake and developed hypertension. Plasma parathyroid hormone concentrations of S and R rats did not differ during low salt intake and increased significantly to the same concentration after 3 weeks of high salt intake.ConclusionsWe have previously reported that plasma 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D concentrations of male S rats, but not male R rats, were drastically reduced by 3 weeks of high salt intake. These data suggest that salt-induced hypertension and salt-induced alterations in the vitamin D endocrine system of male S rats do not affect the calciuric response to dietary salt.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
8. |
Livedo Reticularis: An Underutilized Diagnostic Clue in Cholesterol Embolization Syndrome |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 348-351
Kunal Chaudhary,
Barry Wall,
Ronnie Rasberry,
Preview
|
PDF (89KB)
|
|
摘要:
BackgroundCholesterol embolization syndrome (CES) is an increasingly recognized cause of acute renal insufficiency, which must be differentiated from other forms of systemic vasculitis by histologic examination of biopsies from involved organs. This report describes the optimal methods for detection and biopsy of areas of skin involved with livedo reticularis to confirm the diagnosis of CES.MethodsThis report describes 8 patients with unexplained acute renal insufficiency in whom the diagnosis of CES was suspected based on their clinical history.ResultsA detailed skin examination performed in both supine and upright postures demonstrated the presence of previously unrecognized livedo reticularis, which was more evident during upright posture in all subjects. In 2 subjects, questionable areas of livedo reticularis noted in supine posture became readily demonstrable during upright posture. Livedo reticularis was apparent only during upright posture in 2 subjects. Biopsies of areas of skin involved with livedo reticularis demonstrated cholesterol emboli in 6 of 8 patients and were normal in the remaining 2 patients. One patient progressed to end-stage renal disease and one was lost to follow-up. In the remaining 6 patients, renal insufficiency initially progressed but did not require dialytic therapy. Renal function returned to baseline levels and livedo reticularis resolved without recurrence in these patients. No subjects developed clinical or laboratory evidence of systemic vasculitis.ConclusionsLivedo reticularis is a common but often unrecognized finding in CES that may not be evident during routine examination performed in the supine posture. Deep cutaneous biopsy of areas of livedo reticularis can be safely used to confirm the presence of cholesterol emboli, thus avoiding the increased morbidity of biopsy of either pregangrenous skin lesions or visceral organs. Many patients with CES regain renal function during long-term follow-up.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
9. |
A Woman with Recurrent Abdominal Pain |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 352-354
Darren Schwartz,
Michael Campos,
Preview
|
PDF (508KB)
|
|
摘要:
Papillary cystic and solid tumor of the pancreas is a rare neoplasm with low malignancy potential generally found in young women. Although its presentation is typically one of vague abdominal complaints, its radiographic and histologic characteristics are distinct. Recognition of the clinical and pathological spectrum of papillary cystic and solid tumor of the pancreas is essential for diagnosing this uncommon condition and differentiating it from other pancreatic masses encountered in the young.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
10. |
Atrial Fibrillation in Father and Son after Ingestion of Cold Substances |
|
The American Journal of the Medical Sciences,
Volume 321,
Issue 5,
2001,
Page 355-357
Chun Tan,
Joseph Gerry,
D. Luke Glancy,
Preview
|
PDF (1667KB)
|
|
摘要:
A man and his father each developed atrial fibrillation after the ingestion of a frozen sweet. In the son, atrial fibrillation recurred with the subsequent ingestion of cold beverages. Neither patient had documented episodes of atrial fibrillation at any other time. The son also had multiple other episodes of palpitation, suggesting brief episodes of atrial fibrillation, and these occurred only with the ingestion of cold substances. Possible mechanisms include direct cooling of the left atrium through the wall of the esophagus and autonomic stimulation by the cold substance.
ISSN:0002-9629
出版商:OVID
年代:2001
数据来源: OVID
|
|